Recurrent Clostridioides difficile infection: Recognition, management, prevention

被引:18
|
作者
Tsigrelis, Constantine [1 ,2 ]
机构
[1] Cleveland Clin, Dept Infect Dis, G21,9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44106 USA
关键词
FECAL MICROBIOTA TRANSPLANTATION; CLINICAL-PRACTICE GUIDELINES; HEALTH-CARE EPIDEMIOLOGY; INTESTINAL MICROBIOME; DISEASES SOCIETY; VANCOMYCIN; BEZLOTOXUMAB; UPDATE; ADULTS; FIDAXOMICIN;
D O I
10.3949/ccjm.87gr.20001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clostridioides difficile infection (CDI) is the most common cause of diarrhea in hospitalized patients and results in substantial morbidity, mortality, and costs. Its clinical management, primarily with antibiotics, is often complicated by recurrent episodes. These recurrent CDI episodes are thought to be caused by antibiotic disruption of colonic microbiota and usually occur within 4 weeks of completing antibiotic therapy. The risk of recurrent CDI increases after the first episode, creating a need for management strategies to diagnose, treat, and prevent these complications.
引用
收藏
页码:347 / 359
页数:13
相关论文
共 50 条
  • [31] Pseudomembranes on colostomy in a patient with recurrent Clostridioides difficile infection
    Ueda, Hideki
    Hase, Ryota
    Sato, Akiyuki
    Hosokawa, Naoto
    IDCASES, 2023, 31
  • [32] Recurrent Clostridioides difficile infection: treat the microbiome as well!
    Klein, Friederike
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (05): : 729 - 729
  • [33] Oral microbiome therapy for recurrent Clostridioides difficile infection
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (03): : 205 - 205
  • [34] Risk Factors Associated with Recurrent Clostridioides difficile Infection
    Negrut, Nicoleta
    Bungau, Simona
    Behl, Tapan
    Khan, Shamim Ahmad
    Vesa, Cosmin Mihai
    Bustea, Cristiana
    Nistor-Cseppento, Delia Carmen
    Rus, Marius
    Pavel, Flavia-Maria
    Tit, Delia Mirela
    HEALTHCARE, 2020, 8 (03)
  • [35] EFFICACY AND SAFETY OF MONOCLONAL ANTIBODIES AGAINST CLOSTRIDIOIDES DIFFICILE TOXINS FOR PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION; A SYSTEMATIC REVIEW AND META-ANALYSIS
    Akiyama, Shintaro
    Yamada, Akihiro
    Komaki, Yuga
    Komaki, Fukiko
    Micic, Dejan
    Sakuraba, Atsushi
    GASTROENTEROLOGY, 2020, 158 (06) : S535 - S535
  • [36] Cisplatin-Induced Recurrent Clostridioides difficile Infection
    Pasham, Sudhir Reddy.
    Chakinala, Rajachandra
    Lekkala, Manidhar
    Jala, Saisree Reddy Adla
    Katamreddy, Rewanth
    Ponnekanti, Sravan
    Damughatla, Anirudh R.
    Koleti, Pragna
    Lamichanne, Bikal
    Ravella, Balakrishna
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1613 - S1613
  • [37] Risk factors for Recurrent Clostridioides Difficile Infection in Children
    Lee, Philip
    Nemati, Koorosh
    Silver, Ellen J.
    Cacace, Jessica
    Goldman, David L.
    HOSPITAL PEDIATRICS, 2023, 13 (11) : 1010 - 1017
  • [38] A review of fecal microbiota, live-js']jslm for the prevention of recurrent Clostridioides difficile infection
    Hunt, Aaron
    Drwiega, Emily
    Wang, Yifan
    Danziger, Larry
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (15) : e402 - e411
  • [39] How to: prophylactic interventions for prevention of Clostridioides difficile infection
    Reigadas, Elena
    van Prehn, Joffrey
    Falcone, Marco
    Fitzpatrick, Fidelma
    Vehreschild, Maria J. G. T.
    Kuijper, Ed J.
    Bouza, Emilio
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1777 - 1783
  • [40] SIGNIFICANT CORRELATIONS AMONG CLOSTRIDIOIDES DIFFICILE SPECIES AND PATHOGENIC BACTERIOPHAGES IN PATIENTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION
    Verma, Sandeep
    Firnberg, Elad
    Vinayek, Rakesh
    Nair, Padmanabhan
    Dutta, Sudhir
    GASTROENTEROLOGY, 2022, 162 (07) : S1000 - S1000